Cargando…
The clinical value of biomarkers in respiratory complications in hematopoietic SCT
To determine the role of biomarkers in the clinical management of respiratory complications (RC) in hematopoietic stem cell transplantation (HSCT) recipients, we have prospectively evaluated a cohort of 175 patients followed-up for 1 year after HSCT. To avoid misinterpretation, we have excluded both...
Autores principales: | Lucena, C M, Rovira, M, Gabarrús, A, Filella, X, Martínez, C, Domingo, R, Torres, A, Agustí, C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094688/ https://www.ncbi.nlm.nih.gov/pubmed/27797370 http://dx.doi.org/10.1038/bmt.2016.280 |
Ejemplares similares
-
Pulmonary complications in hematopoietic SCT: a prospective study
por: Lucena, C M, et al.
Publicado: (2014) -
Hematopoietic SCT in Europe: data and trends in 2011
por: Passweg, J R, et al.
Publicado: (2013) -
Bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: phenotypes and prognosis
por: Bergeron, A, et al.
Publicado: (2012) -
Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of
pediatric transplantation
por: Passweg, J R, et al.
Publicado: (2014) -
SCT Barrel
por: Marcelloni Oliveira, C
Publicado: (2005)